| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/27/2013 | EP2560686A2 Selective modification of proteins |
| 02/27/2013 | EP2560684A1 Fibronectin type iii domain-based multimeric scaffolds |
| 02/27/2013 | EP2560675A1 Long-acting gastrin derivatives |
| 02/27/2013 | EP2560672A1 Rtef-1 variants and uses thereof |
| 02/27/2013 | EP2560670A2 Uses of natriuretic peptide constructs |
| 02/27/2013 | CN102947445A Florigen-activating complex |
| 02/27/2013 | CN102947444A Compositions and methods for re-programming cells without genetic modification for treatment of cardiovascular diseases |
| 02/27/2013 | CN102947332A Novel octapeptide compounds and therapeutic use thereof |
| 02/27/2013 | CN102947331A Insulin analogues containing additional disulfide bonds |
| 02/27/2013 | CN102947330A Disulphide bond-stabilized functional soluble mhc class ii heterodimers |
| 02/27/2013 | CN102947329A Diffocins and methods of use thereof |
| 02/27/2013 | CN102947328A Biocatalytic oxidation process with alkL gene product |
| 02/27/2013 | CN102947324A Peptide domains that bind small molecules of industrial significance |
| 02/27/2013 | CN102946914A Methods and combination |
| 02/27/2013 | CN102946899A Pharmaceutical composition |
| 02/27/2013 | CN102946897A Treatment of vascular complications of diabetes |
| 02/27/2013 | CN102943088A Silkworm membrane magnesium transport protein Bm-MMgT expression and purification method |
| 02/27/2013 | CN102943078A Compositions and methods related to silicon transport |
| 02/27/2013 | CN102943076A Cloning and application of beef quality-related gene CMYA1 |
| 02/27/2013 | CN102942626A Glucagon-like peptide-2 analogue, its preparation method and application |
| 02/27/2013 | CN102942625A Solid-phase synthesis method of exenatide |
| 02/27/2013 | CN102942624A Galectin-3 binding protein, preparation and application thereof |
| 02/27/2013 | CN102942623A AtTAR2 protein and application of AtTAR2 protein coding genes to regulation of plant lateral root growth |
| 02/27/2013 | CN102942622A Application of MtSKL1 protein and coding genes of MtSKL1 protein for controlling plant traits |
| 02/27/2013 | CN102942621A Plant powdery mildew resistance related protein TaCAF1 and its coding gene and application |
| 02/27/2013 | CN102942620A Heat-resistant recombinant allophycocyanin beta subunit mutant |
| 02/27/2013 | CN102942619A Bird flu hemagglutinin antigen protective agent and method for improving bird flu hemagglutinin stability in blastochyle |
| 02/27/2013 | CN102942618A Telomeric protein polypeptide fragment with tumor cell killing activity and application thereof |
| 02/27/2013 | CN102942519A Nitenpyram hapten, artificial antigen and antibody, their preparation methods and application thereof |
| 02/27/2013 | CN102940880A Growth factor complex |
| 02/27/2013 | CN102408481B Preparation method for pea aspartic acid protease inhibitor |
| 02/27/2013 | CN102408479B Preparation method for artificial antigen of erythrosin pigment |
| 02/27/2013 | CN102260348B Pteromalus puparum venom serine protease inhibitor Pp-PI polypeptide and application thereof |
| 02/27/2013 | CN102219839B Gene SRL-1 for controlling leaf shape of paddy rice and application thereof |
| 02/27/2013 | CN102080088B Cotton dehydrin similar gene and application thereof |
| 02/27/2013 | CN102079788B Method for detecting sulfanilamide medicine and special enzyme-linked immunoassay reagent kit thereof |
| 02/27/2013 | CN101948518B Method for preparing functional protein RJCPs by royal jelly and application |
| 02/27/2013 | CN101613398B Surface lipoprotein of streptococcus suis type-2, preparation method thereof and application |
| 02/27/2013 | CN101578295B Novel antigens and antibodies associated to pancreatic ductal adenocarcinoma |
| 02/27/2013 | CN101497883B Expression production and separation purification of recombinant placenta growth factor and chemical marker thereof |
| 02/27/2013 | CN101213301B Rnai for control of insects and arachnids |
| 02/27/2013 | CN101111516B Conjugates of biologically active proteins having a modified in vivo half-life |
| 02/26/2013 | US8386898 Method and apparatus for data transmission using multiple transmit antennas |
| 02/26/2013 | US8383919 Highly fluorescent peptide-metallic nanoclusters as bio-probes and methods of synthesis thereof |
| 02/26/2013 | US8383891 Wuschel (WUS) gene homologs |
| 02/26/2013 | US8383799 Translocation and mutant ROS kinase in human non-small cell lung carcinoma |
| 02/26/2013 | US8383790 Modified surface antigen |
| 02/26/2013 | US8383788 For therapy of cancer or tumorous growth |
| 02/26/2013 | US8383780 Antibodies to TGFβ |
| 02/26/2013 | US8383777 13-transmembrane protein expressed in prostate cancer |
| 02/26/2013 | US8383776 Purification of factor XIII polypeptides from biological materials |
| 02/26/2013 | US8383775 Cytokine zalpha11 ligand |
| 02/26/2013 | US8383774 Collectin fusion proteins comprising TNF or trail |
| 02/26/2013 | US8383773 Protein product and method for reducing biomass-biomass interactions |
| 02/26/2013 | US8383771 Altered peptide ligand derived from HSP60 and pharmaceutical compositions |
| 02/26/2013 | US8383767 Immunogenic protein carrier containing an antigen presenting cell binding domain and a cysteine-rich domain |
| 02/26/2013 | US8383766 Zinc finger protein for use as transcriptional modulator |
| 02/26/2013 | US8383604 Modulation of BCL11A for treatment of hemoglobinopathies |
| 02/26/2013 | US8383592 Apo A-I mimetic peptides and methods of treatment |
| 02/26/2013 | US8383587 Prevention of allergy at weaning |
| 02/26/2013 | US8383575 (DI)barnase-barstar complexes |
| 02/26/2013 | US8383388 for oral administration; exhibit increased protein stability; exhibit increased stability in the bloodstream, following oral administration, and/or under storage conditions |
| 02/26/2013 | US8383371 Nucleic acid construct containing a nucleic acid derived from the genome of hepatitis C virus (HCV) of genotype 2a, and a cell having such nucleic acid construct introduced therein |
| 02/26/2013 | US8383366 Enhanced protein expression in Bacillus |
| 02/26/2013 | US8383365 Methods of making FGF-21 mutants comprising non-naturally encoded phenylalanine derivatives |
| 02/26/2013 | US8383363 L-amino acid-producing microorganism and method for producing L-amino acid |
| 02/26/2013 | US8383333 HBV precore protein capable of forming particles |
| 02/26/2013 | US8383133 Conjugates of Plasmodium falciparum surface proteins as malaria vaccines |
| 02/26/2013 | US8383130 Partial peptide of lacritin |
| 02/26/2013 | US8383129 Employment of rotavirus proteins, derived proteins and peptides for the modulation of tissue permeability |
| 02/26/2013 | US8383126 Bacterial pheromones and uses thereof |
| 02/26/2013 | US8383125 Antimicrobial protein |
| 02/26/2013 | US8383117 CD44E tumor specific antibody |
| 02/26/2013 | US8383114 Pharmaceutical formulations |
| 02/26/2013 | US8383107 Single domain brain-targeting antibody fragments derived from llama antibodies |
| 02/26/2013 | US8383096 Cancer immunotherapy with a viral antigen-defined, immunomodulator-secreting cell vaccine |
| 02/26/2013 | US8383083 Polymer precursors of radiolabeled compounds, and methods of making and using the same |
| 02/26/2013 | CA2674885C Anti-ige vaccines |
| 02/26/2013 | CA2674837C Anti-ige vaccines |
| 02/26/2013 | CA2633345C A method of affinity separation and ligands for use therein |
| 02/26/2013 | CA2632013C Adenovirus 36 e4 orf 1 gene and protein and their uses |
| 02/26/2013 | CA2542035C Process for producing antithrombin iii composition |
| 02/26/2013 | CA2524399C Optimized fc variants and methods for their generation |
| 02/26/2013 | CA2493822C Methods and compositions for targeting secretory lysosomes |
| 02/26/2013 | CA2493406C Gm-negative ehv-mutants without heterologous elements |
| 02/26/2013 | CA2492068C Assays for assembly of ebola virus nucleocapsids |
| 02/26/2013 | CA2477312C Use of soluble fgl2 as an immunosuppressant |
| 02/26/2013 | CA2440775C The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use |
| 02/26/2013 | CA2430115C Recombinant rsv virus expression systems and vaccines |
| 02/26/2013 | CA2389644C A novel polypeptide hormone phosphatonin |
| 02/26/2013 | CA2380302C Production of proteins by autoproteolytic cleavage |
| 02/26/2013 | CA2350335C Host cells expressing recombinant human erythropoietin |
| 02/26/2013 | CA2324648C Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items |
| 02/26/2013 | CA2324381C An integrin heterodimer and a subunit thereof |
| 02/21/2013 | WO2013026015A1 Muc1 ligand traps for use in treating cancers |
| 02/21/2013 | WO2013025945A2 Variant sucrose transporter polypeptides that enable faster sucrose utilization in bacteria |
| 02/21/2013 | WO2013025928A2 Methods for extracting keratin proteins |
| 02/21/2013 | WO2013024904A1 A method for producing an l-amino acid using a bacterium of the family enterobacteriaceae having enhanced expression of the flagella formation and motility cascade genes |
| 02/21/2013 | WO2013024243A1 Inhibitors against endosomal/lysosomal enzymes |
| 02/21/2013 | WO2013024111A1 Biotechnological synthesis process of organic compounds with the aid of an alkl gene product |